MNPR-101-800F

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMNPR-101-800F
Drug Alias NameMNPR 101 800FMNPR-101-800F
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionDiagnostic imaging enhancers
TargetsNot applicable
Therapy Area/IndicationsUrinary Bladder Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMonopar Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesMonopar Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsUrinary Bladder Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A